# PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma

> **NCT07018518** · PHASE1 · RECRUITING · sponsor: **Chinese PLA General Hospital** · enrollment: 25 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Adult

## Interventions

- **BIOLOGICAL:** PIN +anti-PD1

## Key facts

- **NCT ID:** NCT07018518
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-20
- **Primary completion:** 2026-07-31
- **Final completion:** 2030-12-01
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07018518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07018518, "PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07018518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*